Looking for factors affecting functioning in euthymic patients with bipolar I disorder: the importance of cognitive complaints and BDNF's Val66Met polymorphism

被引:4
|
作者
Yoldi-Negrete, Maria [1 ]
Palacios-Cruz, Lino [1 ]
Tirado-Duran, Elsa [2 ]
Ivonne Jimenez-Rodriguez, Laura [2 ]
Jimenez-Pavon, Joanna [3 ]
Hernandez, Sandra [4 ]
Aguilar, Alejandro [4 ]
Pamela Morales-Cedillo, Ingrid [4 ]
Jimenez-Tirado, Mariana [5 ]
Fresan-Orellana, Ana [1 ]
Juarez Garcia, Francisco [6 ]
Becerra-Palars, Claudia [7 ]
Camarena-Medellin, Beatriz [4 ]
机构
[1] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Lab Epidemiol Clin, Subdirecc Invest Clin, Mexico City, DF, Mexico
[2] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Neuropsicol, Direcc Serv Clin, Mexico City, DF, Mexico
[3] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Serv Clin, Clin Trastornos Afectivos, Mexico City, DF, Mexico
[4] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Farmacogenet, Subdirecc Invest Clin, Mexico City, DF, Mexico
[5] Hosp Med Sur, Dept Ensenanza, Mexico City, DF, Mexico
[6] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Invest Epidemiol & Sociales, Mexico City, DF, Mexico
[7] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Serv Clin, Mexico City, DF, Mexico
关键词
Bipolar disorder; Functionality; Cognition; Val66Met; BDNF; RATING ASSESSMENT COBRA; QUALITY-OF-LIFE; NEUROTROPHIC FACTOR; PERFORMANCE; SCHIZOPHRENIA; ANXIETY; IMPAIRMENT; RECOVERY; MOOD; ASSOCIATION;
D O I
10.1016/j.jad.2022.01.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Functioning in Bipolar Disorder (BD) is affected in a substantial proportion of patients. The impact of demographic, clinical, cognitive, and genetic factors on functioning has been shown individually; however, as a complex phenomenon, a global approach to identify the most relevant as well as possible interactions is needed. Methods: 102 patients with type I BD in euthymia were invited for evaluation of demographic, clinical, and cognitive characteristics as well as genotype for Val66Met polymorphism of BDNF gene to determine those associated with poor functioning according to the FAST scale cut-off score. Clinical evaluation included assessment of residual affective symptoms and anxiety. Cognitive evaluation included the COBRA scale, verbal memory, and executive functions testing. Results: Residual depressive symptoms, anxiety, cognitive complaints and being a Met carrier were more frequent in the poor functioning group and were entered in a logistic regression model. Being a Met carrier (OR=4.46, CI=1.19-16.67) and cognitive complaints (OR=1.29, CI= 1.13-1.46) were the most important predictors of poor functioning in type I BD. Limitations: Cross-sectional study, with select population limiting generalizability of findings. Conclusions: A better understanding of underlying factors affecting cognition, including the possible involvement of BDNF Val66Met polymorphism, its systematic evaluation and a continued search for targeted treatment, along with recognition and attention of residual affective and anxious symptoms might improve psychosocial outcomes such as functioning in this population.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [31] Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls
    Zhen, Yan-Feng
    Liu, Xing-Yu
    Zhou, Dong-Hao
    Du, Xiangdong
    Yin, Guangzhong
    Zhang, Yingyang
    Fang, Hui
    Xu, Gang
    Soares, Jair C.
    Zhang, Xiang Yang
    ONCOTARGET, 2018, 9 (03) : 3653 - 3662
  • [32] The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia
    Chen, Shiou-Lan
    Lee, Sheng-Yu
    Chang, Yun-Hsuan
    Chen, Shih-Heng
    Chu, Chun-Hsien
    Wang, Tzu-Yun
    Chen, Po-See
    Lee, I-Hui
    Yang, Yen-Kuang
    Hong, Jau-Shyong
    Lu, Ru-Band
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 51 : 99 - 104
  • [33] Does BDNF Val66Met Polymorphism Confer Risk for Posttraumatic Stress Disorder?
    Wang, Tengfei
    NEUROPSYCHOBIOLOGY, 2015, 71 (03) : 149 - 153
  • [34] Interaction effects of anxiety and the BDNF Val66Met polymorphism on attention in patients with schizophrenia spectrum disorders
    Golimbet, V. E.
    Lebedeva, I. S.
    Alfimova, M. V.
    Korovaitseva, G. I.
    Lezheiko, T. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (10) : 49 - 54
  • [35] The BDNF Val66Met polymorphism is not associated with myocardial infarction in Czech patients
    Stahelova, A.
    Petrkova, J.
    Motakova, N.
    Taborsky, M.
    Mrazek, F.
    Petrek, M.
    CYTOKINE, 2011, 53 (01) : 13 - 14
  • [36] The BDNF Val66Met polymorphism is associated with escitalopram response in depressed patients
    El-Hage, Wissam
    Vourc'h, Patrick
    Gaillard, Philippe
    Leger, Julie
    Belzung, Catherine
    Ibarguen-Vargas, Yadira
    Andres, Christian R.
    Camus, Vincent
    PSYCHOPHARMACOLOGY, 2015, 232 (03) : 575 - 581
  • [37] Gender-modulated influence of BDNF concentration and Val66Met polymorphism on cognitive outcomes in chronic limb ischemia patients
    Chyrek-Tomaszewska, Aleksandra
    Popiolek, Alicja
    Stachowicz-Karpinska, Agnieszka
    Budzynski, Jacek
    Linkowska, Katarzyna
    Kozakiewicz, Mariusz
    Szelagowski, Adam
    Borkowska, Alina
    Bielinski, Maciej
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [38] The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders
    Zhang, Yinghua
    Wei, Xinyue
    Zhang, Wenhao
    Jin, Feng
    Cao, Wenbo
    Yue, Mingjin
    Mo, Saijun
    AIMS NEUROSCIENCE, 2024, 11 (02) : 188 - 202
  • [39] Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder
    Lohoff, FW
    Sander, T
    Ferraro, TN
    Dahl, JP
    Gallinat, J
    Berrettini, WH
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 139B (01) : 51 - 53
  • [40] BDNF Val66Met polymorphism and cognitive impairment in Parkinson’s disease—a meta-analysis
    Yanying Yin
    Xuening Su
    Lishou Pan
    Chen Li
    Neurological Sciences, 2019, 40 : 1901 - 1907